Elanco Animal Health (ELAN) EBT (2017 - 2026)
Elanco Animal Health (ELAN) reported EBT of $87.0 million for Q1 2026, up 45.0% on a YoY basis from $60.0 million in Q1 2025, and up 133.59% sequentially from -$259.0 million in Q4 2025.
Elanco Animal Health (ELAN) EBT (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of EBT data on file, last reported at $87.0 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 45.0% year-over-year to $87.0 million; the trailing twelve-month figure through Mar 2026 stood at -$197.0 million (down 136.75% YoY), and the FY2025 full-year result was -$224.0 million, down 145.9% from the prior year.
- EBT climbed to $87.0 million in Q1 2026, from -$259.0 million in the prior quarter.
- In the past five years, EBT ranged from a high of $559.0 million in Q3 2024 to a low of -$1.1 billion in Q3 2023.
- A 5-year average of -$53.9 million and a median of -$32.0 million in 2024 frame the typical range for EBT.
- Across the five-year window, EBT sank 2393.18% in 2023 and soared 400.0% in 2025, its largest moves.
- Tracing ELAN's EBT over 5 years: stood at -$89.0 million in 2022, then sank by 42.7% to -$127.0 million in 2023, then surged by 59.84% to -$51.0 million in 2024, then plunged by 407.84% to -$259.0 million in 2025, then soared by 133.59% to $87.0 million in 2026.
- Business Quant data shows ELAN's EBT at $87.0 million in Q1 2026, -$259.0 million in Q4 2025, and -$50.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 437.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 758.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.90 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 318.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -247.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 246.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 87.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | -4.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.00 Mn |
| Dec 31, 2025 | -259.00 Mn |
| Sep 30, 2025 | -50.00 Mn |
| Jun 30, 2025 | 25.00 Mn |
| Mar 31, 2025 | 60.00 Mn |
| Dec 31, 2024 | -51.00 Mn |
| Sep 30, 2024 | 559.00 Mn |
| Jun 30, 2024 | -32.00 Mn |
| Mar 31, 2024 | 12.00 Mn |
| Dec 31, 2023 | -127.00 Mn |
| Sep 30, 2023 | -1.10 Bn |
| Jun 30, 2023 | -79.00 Mn |
| Mar 31, 2023 | 108.00 Mn |
| Dec 31, 2022 | -89.00 Mn |
| Sep 30, 2022 | -44.00 Mn |
| Jun 30, 2022 | -14.00 Mn |
| Mar 31, 2022 | 75.00 Mn |
| Dec 31, 2021 | -120.00 Mn |
| Sep 30, 2021 | -130.00 Mn |
| Jun 30, 2021 | -243.00 Mn |